phenylmethylpyrazolone (CID 4021) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(30)
 
 
Inactive(1173)
 
 
Inconclusive(80)
 
 
Unspecified(174)
 
 
Top Targets:
7TM GPCR Srx(32)
 
 
 
7TM GPCR Srsx(21)
 
 
 
p450(20)
 
 
 
 
 
NR LBD TR(16)
 
 
NR LBD PPAR(16)
 
 
 
BioAssay Types:
Screening(557)
 
 
 
 
Confirmatory(549)
 
 
 
 
 
Literature(113)
 
 
 
 
 
BioActivity Types:
Potency(417)
 
 
 
 
 
IC50(168)
 
 
 
 
EC50(15)
 
 
 
 
AC50(2)
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 1151    Data Row: 1457   Total Pages: 30   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103219212]
IC50 0.25Hydroxy radical scavenging activity by ESR spin-trapping method [AID298289, Type: Literature]
View
2
[SID855774]
AC50 2.753Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Inhibitors of DnaB-Intein Splicing Activity [AID449749, Type: confirmatory]replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200]
View
3
[SID855774]
EC50 2.95Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity [AID435010, Type: confirmatory]DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874]
View
4
[SID855774]
EC50 3.099Fluorescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of GFP Chromophore Formation [AID434968, Type: confirmatory]DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874]
View
5
[SID855774]
AC50 3.243Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Non-Covalent Inhibitors of RecA-Intein Splicing Activity [AID449750, Type: confirmatory]replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200]
View
6
[SID26757432]
Potency 3.9811Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
7
[SID26757432]
Potency 3.9811Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
8
[SID26757432]
Potency 3.9811Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
9
[SID26757432]
Potency 3.9811Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
10
[SID26746991]
Potency 5.0119qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
11
[SID26746991]
Potency 5.0119qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
12
[SID17389763]
Potency 10qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
13
[SID17389763]
Potency 10qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
14
[SID855774]
Potency 10qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
15
[SID855774]
Potency 10qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
16
[SID103219212]
IC50 17Antioxidant activity against Fe2SO4/ascorbate-induced lipid peroxidation in Wistar rat liver microsomal membrane by TBARS assay [AID412356, Type: Literature]
View
17
[SID17389763]
Potency 25.1189qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory]cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386]
View
18
[SID17389763]
Potency 25.1189qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory]cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386]
View
19
[SID17389763]
Potency 25.1189qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory]cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386]
View
20
[SID103219212]
IC50 27Antioxidant effect assessed as DPPH radical scavenging activity [AID283751, Type: Literature]
View
21
[SID103219212]
IC50 29.3Scavenging activity against DPPH [AID226891, Type: Literature]
View
22
[SID103219212]
IC50 32Compound tested to inhibit (LPO) lipid peroxidation was determined in rat brain microsomes [AID181671, Type: Literature]
View
23
[SID103219212]
 Neuroprotective effect against H202-induced Sprague-Dawley rat cortical neuron injury assessed as cell viability at 100 uM treated 30 mins before H202 challenge measured after 24 hrs by MTT assay [AID349364, Type: Literature]
View
24
[SID855774]
 Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other]
View
25
[SID11113339]
 Cytochrome panel assay with activity outcomes [AID1851_4, Type: other]cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100]
View
26
[SID11113339]
 Cytochrome panel assay with activity outcomes [AID1851_4, Type: other]cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100]
View
27
[SID11113339]
 p450-cyp1a2 [AID410, Type: confirmatory]cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100]
View
28
[SID11113339]
 p450-cyp1a2 [AID410, Type: confirmatory]cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100]
View
29
[SID11113339]
 p450-cyp1a2 [AID410, Type: confirmatory]cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100]
View
30
[SID855774]
 uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID489030, Type: screening]Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397]
View
31
[SID855774]
IC50 AlphaScreen confirmatory assay for validation of inhibitors of SUMOylation [AID2018, Type: confirmatory]SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785]
View
32
[SID855774]
 Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2) [AID604, Type: screening]rho-associated protein kinase 2 [Homo sapiens] [gi:41872583]
View
33
[SID855774]
 Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2) [AID604, Type: screening]rho-associated protein kinase 2 [Homo sapiens] [gi:41872583]
View
34
[SID855774]
 Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition [AID1481, Type: screening]Valosin-containing protein [Homo sapiens] [gi:111305821]
View
35
[SID855774]
 Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition [AID1481, Type: screening]Valosin-containing protein [Homo sapiens] [gi:111305821]
View
36
[SID85148637]
 TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening]Methyl-CpG binding domain protein 2 [Homo sapiens] [gi:21595776]
View
37
[SID56422481]
 Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening]glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484]
View
38
[SID56422481]
 Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening]glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484]
View
39
[SID855774]
 Novel Modifiers of Toll-like and RIG-like Receptor Signaling-Poly IC Stimulus [AID602277, Type: screening]Toll-like receptor 3 [gi:20140422]
View
40
[SID85148637]
 Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening]putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066]
View
41
[SID855774]
 Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK [AID555, Type: screening]mevalonate kinase [Streptococcus pneumoniae D39] [gi:116516899]
View
42
[SID855774]
 Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity [AID2221, Type: screening]DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874]
View
43
[SID56422481]
 uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) [AID602440, Type: screening]SENP8 gene product [Homo sapiens] [gi:262118306]
View
44
[SID56422481]
 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening]protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487]
View
45
[SID56422481]
 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening]protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487]
View
46
[SID103219212]
IC50 1Antiprion activity in ScN2a cells assessed as inhibition of protease-resistant prion protein accumulation [AID298287, Type: Literature]
View
47
[SID103219212]
IC50 250Hydroxyl radical scavenging activity by ESR spin-trapping method [AID276888, Type: Literature]
View
48
[SID103219212]
 Antioxidant effect against hydrogen peroxide-induced impairment in PC12 cells assessed as cell viability at 0.4 uM by MTT assay relative to control [AID283747, Type: Literature]
View
49
[SID103219212]
 The concentration producing 50% protection against L-HCA-mediated neurotoxicity in HT-22 hippocampal cell line. [AID85745, Type: Literature]
View
50
[SID103219212]
 The concentration producing 50% toxicity in HT-22 hippocampal cell line. [AID85746, Type: Literature]
View